Nicotine

Clean Remedies Highlights Two Energy Boosting CBD Infused Products

Friday, June 11, 2021 - 1:38pm

Clean Remedies has Organic Sour CBD Gummies and CBD Pouches .

Key Points: 
  • Clean Remedies has Organic Sour CBD Gummies and CBD Pouches .
  • For those looking for an oral fixation without the use of tobacco or nicotine products, Clean Remedies CBD Pouches can be a friendly alternative.
  • Both items in Clean Remedies' energy-boost CBD product line can help people reinvigorate their daily routine.
  • Using all-natural ingredients, CBD Power Pouches and CBD Sour Gummies can help you get through the day without that caffeine burnout.

Argentina Heated Tobacco and Oral Tobacco Regulatory Report 2021 - ResearchAndMarkets.com

Thursday, June 10, 2021 - 2:59pm

The "Regulatory Report: Argentina - Heated Tobacco and Oral Tobacco" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Regulatory Report: Argentina - Heated Tobacco and Oral Tobacco" report has been added to ResearchAndMarkets.com's offering.
  • The regulation of heated tobacco and modern oral products, such as tobacco-free nicotine pouches or snus containing tobacco, will remain unchanged in Argentina for the foreseeable future.
  • For the time being, it does not seem to be a priority for the authorities to establish a clear regulatory framework for heated tobacco products, which means that they will remain under the legal framework of tobacco products.
  • This initiative has already been proposed by countries such as the UK and New Zealand, which seek the same by 2030 and 2025 respectively.

Omeros Announces Publication Detailing the Mechanism of Action of PDE7 In Nicotine Addiction

Thursday, June 10, 2021 - 1:45pm

Specifically, inhibitors of PDE7 reduced nicotine consumption and relapse in rodent models of nicotine abuse.

Key Points: 
  • Specifically, inhibitors of PDE7 reduced nicotine consumption and relapse in rodent models of nicotine abuse.
  • The research was conducted in collaboration with the School of Pharmacy of the University of Camerino in Italy.
  • Recent developments such as forms of electronic nicotine delivery are contributing to a new surge of nicotine use, especially in young adults.
  • Omeros owns global rights to the use of PDE7 inhibitors for the treatment of addictive disorders.

South Korea e-Cigarette Regulatory Report 2021 - ResearchAndMarkets.com

Wednesday, June 9, 2021 - 6:04pm

The "E-cigarette Regulatory Report: South Korea" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "E-cigarette Regulatory Report: South Korea" report has been added to ResearchAndMarkets.com's offering.
  • E-cigarettes with nicotine are regulated as tobacco products under the Tobacco Business Act.
  • For this reason, importers may try to circumvent requirements placed on tobacco products by declaring them as containing extracts from tobacco stems or roots.
  • To tackle this problem, the current government - just like the previous - is trying to redefine tobacco products as those being derived from any part of the tobacco plant.

Finland HNB, Oral Tobacco and Nicotine Pouches Regulatory Report 2021 - ResearchAndMarkets.com

Wednesday, June 9, 2021 - 11:24am

The "Regulatory Report: Finland - HNB, Oral Tobacco and Nicotine Pouches" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Regulatory Report: Finland - HNB, Oral Tobacco and Nicotine Pouches" report has been added to ResearchAndMarkets.com's offering.
  • Taxes for new products (for example, e-cigarette tax, which is 0.30/ml, regardless of nicotine content) are among the highest in the European Union.
  • Tobacco-free nicotine pouches are regulated in Finland by the Medicines Act and the Medicines Decree.
  • The Finnish Medicines Agency (Fimea) confirmed that there is only one legal medicinal nicotine pouch product on the market in Finland - Zonnic.

Hong Kong HNB, Oral Tobacco and Nicotine Pouches Regulatory Report 2021 - ResearchAndMarkets.com

Wednesday, June 9, 2021 - 11:21am

The "Regulatory Report: Hong Kong - HNB, Oral Tobacco and Nicotine Pouches" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Regulatory Report: Hong Kong - HNB, Oral Tobacco and Nicotine Pouches" report has been added to ResearchAndMarkets.com's offering.
  • Since 2019 the authorities in Hong Kong have been considering a ban on alternative smoking products such as e-cigarettes, heated tobacco and herbal sticks (tobacco-free).
  • However, Hong Kong Customs has de facto prohibited the import of heated tobacco products, by not issuing licences, suggesting an antagonistic overall policy towards reduced-risk tobacco products.
  • The current ban on oral tobacco products and the pharmaceutical classification of nicotine pouches are not expected to change in short term.

Blockbuster Mayweather vs Paul Boxing Match Provided Global Exposure for TAAT™, Driving New Engagement and E-Commerce Activity

Tuesday, June 8, 2021 - 8:01am

The Company has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in "Original", "Smooth", and "Menthol" varieties.

Key Points: 
  • The Company has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in "Original", "Smooth", and "Menthol" varieties.
  • TAAT's base material is Beyond Tobacco, a proprietary blend which undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco.
  • The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration.
  • Disclosures relating to investor relations firms retained by TAAT Global Alternatives Inc. can be found under the Company's profile on http://sedar.com .

On World No Tobacco Day, Foundation for a Smoke-Free World Urges Smokers to Quit or Switch to Harm-Reduction Products

Friday, May 28, 2021 - 8:00am

The calls by the World Health Organization (WHO) for smokers to quit using fairly ineffective interventions suggest we need new approaches.

Key Points: 
  • The calls by the World Health Organization (WHO) for smokers to quit using fairly ineffective interventions suggest we need new approaches.
  • On this WNTD (May 31), the Foundation urges adult smokers to commit to quit smoking combustibles and chewing toxic smokeless tobacco products or switch to a growing range of less harmful nicotine-based alternatives.
  • However, they never mention a role for tobacco harm-reduction (THR) products as part of tobacco control policy.
  • Denying the value and benefits of THR products is irresponsible and blatantly discounts the research showing they can help smokers quit."

Lexaria DehydraTECH(TM) 2.0 Outperforms MCT in 2021 R&D Study

Tuesday, May 25, 2021 - 1:30pm

They recently released R&D study results for three new DehydraTECHTM 2.0 formulation variations that significantly outperformed traditional MCT oil-based formulations that have become CBD industry standard.

Key Points: 
  • They recently released R&D study results for three new DehydraTECHTM 2.0 formulation variations that significantly outperformed traditional MCT oil-based formulations that have become CBD industry standard.
  • Though new to NASDAQ, Lexaria Bioscience Corp. has been producing positive test results with their patented DehydraTECHTM bio-absorption technology since 2016.
  • But now, test results from May of 2021 showed a CBD delivery rate that was up to 2,708% stronger than medium chain triglyceride (MCT) oils which have become industry standard.
  • In November of 2020, Lexaria published a list of 2021 strategic initiatives that also targets hypertension treatment, nicotine delivery, and antiviral absorption.

22nd Century to Participate in May and June 2021 Investor Conferences

Monday, May 24, 2021 - 2:06pm

Institutional investors and those invited to attend these virtual conference events may request one-on-one meetings with representatives of the Company, where offered, through the respective conference hosts or by contacting 22nd Century Groups investor relations via investorrelations@xxiicentury.com .

Key Points: 
  • Institutional investors and those invited to attend these virtual conference events may request one-on-one meetings with representatives of the Company, where offered, through the respective conference hosts or by contacting 22nd Century Groups investor relations via investorrelations@xxiicentury.com .
  • 22nd Century Group, Inc. (NYSE American: XXII ) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding.
  • 22nd Centurys primary mission in tobacco is to reduce the harm caused by smoking through the Companys reduced nicotine content tobacco cigarettes containing 95% less nicotine than conventional cigarettes.
  • The Companys primary mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants with valuable cannabinoid profiles and desirable agronomic traits.